The characterization, cytotoxicity, macrophage response and tissue regeneration of decellularized cartilage in costal cartilage defects
Source abstract
Abstract
After harvesting multiple costal cartilages, the local defect disrupts the integrity of the chest wall and may lead to obvious thoracic complications, such as local depression and asymmetry of the bilateral thoracic height. Decellularized materials have been used for tissue reconstruction in clinical surgeries. To apply xenogenic decellularized cartilage in costal cartilage defects, porcine-derived auricular and costal cartilage was tested for characterization, cytotoxicity, macrophage response, and tissue regeneration. Most of the DNA and α-Gal were effectively removed, and the collagen was well preserved after the decellularization process. The glycosaminoglycan (GAG) content decreased significantly compared to that in untreated cartilage. The decellularized auricular cartilage had a larger pore size, more pores, and a higher degradation rate than the decellularized costal cartilage. No apparent nuclei or structural damage was observed in the extracellular matrix. The decellularized auricular cartilage had a higher cell proliferation rate and more prominent immunomodulatory effect than the other groups. Two types of decellularized cartilage, particularly decellularized auricular cartilage, promoted the tissue regeneration in the cartilage defect area, combined with noticeable cartilage morphology and increased chondrogenic gene expression. In our research, the functional components and structure of the extracellular matrix were well preserved after the decellularization process. The decellularized cartilage had better biocompatibility and suitable microenvironment for tissue regeneration in the defect area, suggesting its potential application in cartilage repair during the surgery. STATEMENT OF SIGNIFICANCE: Autologous costal cartilage has been widely used in various surgeries, while the cartilage defects after the harvesting of multiple costal cartilages may cause localized chest wall deformities. Decellularized cartilage is an ideal material that could be produced in the factory and applied in surgeries. In this study, both decellularized costal cartilage and auricular cartilage preserved original structure, functional biocompatibility, immunosuppressive effects, and promoted tissue regeneration in the cartilage defect area.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Tracheal and airway disorders · Reconstructive Surgery and Microvascular Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Chest wall deformities and thoracic scoliosis after costal cartilage graft harvesting10.1097/00006534-199704000-00017 ↗
2. Three-dimensional computed tomography reveals different donor-site deformities in adult and growing microtia patients despite total subperichondrial costal cartilage harvest and donor-site reconstruction10.1097/01.prs.0000438052.14011.0a ↗
3. A new method of costal cartilage harvest for total auricular reconstruction: part II. Evaluation and analysis of the regenerated costal cartilage10.1097/01.prs.0000244880.12256.7c ↗
4. Effects of human amniotic fluid on costal cartilage regeneration (an experimental study)10.1055/s-0031-1280043 ↗
5. Management of chest deformity caused by microtia reconstruction: Comparison of autogenous diced cartilage versus cadaver cartilage graft partial filling techniques10.1016/j.bjps.2016.09.015 ↗
6. Tissue engineering of heart valves–human endothelial cell seeding of detergent acellularized porcine valves10.1016/S1010-7940(98)00171-7 ↗
7. Process development of an acellular dermal matrix (ADM) for biomedical applications10.1016/j.biomaterials.2003.09.070 ↗
8. Functional decellularized fibrocartilaginous matrix graft for rotator cuff enthesis regeneration: A novel technique to avoid in-vitro loading of cells10.1016/j.biomaterials.2020.119996 ↗
9. Decellularized Cartilage Directs Chondrogenic Differentiation: Creation of a Fracture Callus Mimetic10.1089/ten.tea.2017.0450 ↗
10. Regeneration of human-ear-shaped cartilage with acellular cartilage matrix-based biomimetic scaffolds
11. Processed xenogenic cartilage as innovative biomatrix for cartilage tissue engineering: effects on chondrocyte differentiation and function10.1002/term.1650 ↗
12. Bhattacharya · Novel decellularized animal conchal cartilage graft for application in human patient · 2019 · 13 · 46
13. Hyaluronic acid doped-poly(3,4-ethylenedioxythiophene)/chitosan/gelatin (PEDOT-HA/Cs/Gel) porous conductive scaffold for nerve regeneration, Materials Science & Engineering C
14. Characteristics of cartilage engineered from human pediatric auricular cartilage10.1097/00006534-199904010-00001 ↗
15. Regulation of osteoblast differentiation by Runx210.1007/978-1-4419-1050-9_5 ↗
16. Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation10.1002/jbmr.2287 ↗
17. A novel mouse model of intervertebral disc degeneration shows altered cell fate and matrix homeostasis10.1016/j.matbio.2018.03.019 ↗
18. The influence of biological motifs and dynamic mechanical stimulation in hydrogel scaffold systems on the phenotype of chondrocytes10.1016/j.biomaterials.2010.10.017 ↗
19. Decellularized matrices in regenerative medicine10.1016/j.actbio.2018.04.044 ↗
20. An overview of tissue and whole organ decellularization processes10.1016/j.biomaterials.2011.01.057 ↗
21. The first tissue-engineered airway transplantation: 5-year follow-up results10.1016/S0140-6736(13)62033-4 ↗
22. Fabrication and repair of cartilage defects with a novel acellular cartilage matrix scaffold10.1089/ten.tec.2009.0444 ↗
23. Tissue-engineered trachea regeneration using decellularized trachea matrix treated with laser micropore technique10.1016/j.actbio.2017.05.010 ↗
24. Decellularized cartilage matrix scaffolds with laser-machined micropores for cartilage regeneration and articular cartilage repair, Materials Science & Engineering C
25. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells10.1016/S0021-9258(19)77900-9 ↗
26. A unique natural human IgG antibody with anti-alpha-galactosyl specificity10.1084/jem.160.5.1519 ↗
27. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation10.1097/00007890-199312000-00031 ↗
28. Repair and tissue engineering techniques for articular cartilage10.1038/nrrheum.2014.157 ↗
29. Heparan sulfate: decoding a dynamic multifunctional cell regulator10.1016/S0962-8924(00)01897-3 ↗
30. Incorporation of aggrecan in interpenetrating network hydrogels to improve cellular performance for cartilage tissue engineering10.1089/ten.tea.2012.0160 ↗
31. Heparan sulfate as a regulator of endochondral ossification and osteochondroma development10.1016/j.matbio.2013.11.003 ↗
32. Jiang · Cryoprotectant enables structural control of porous scaffolds for exploration of cellular mechano-responsiveness in 3D · 2019 · 10 · 3491
33. Decellularized cartilage as a prospective scaffold for cartilage repair10.1016/j.msec.2019.04.002 ↗
34. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells induced by acellular cartilage sheets10.1016/j.biomaterials.2012.04.054 ↗
35. Macrophage cytokines: involvement in immunity and infectious diseases10.3389/fimmu.2014.00491 ↗
36. The host response to naturally-derived extracellular matrix biomaterials10.1016/j.smim.2017.01.002 ↗
37. Applications of biomaterials for immunosuppression in tissue repair and regeneration10.1016/j.actbio.2021.03.019 ↗
38. Biomaterials/tissue interactions: possible solutions to overcome foreign body response10.1208/s12248-010-9175-3 ↗
39. Cytokines, inflammation, and pain10.1097/AIA.0b013e318034194e ↗
40. Tailoring materials for modulation of macrophage fate10.1002/adma.202004172 ↗
41. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis10.1002/art.27290 ↗
42. Osteogenic differentiation of bone marrow MSCs by β-tricalcium phosphate stimulating macrophages via BMP2 signalling pathway10.1016/j.biomaterials.2013.11.014 ↗
43. Cartilage repair in degenerative osteoarthritis mediated by squid type II collagen via immunomodulating activation of M2 macrophages, inhibiting apoptosis and hypertrophy of chondrocytes10.1016/j.biomaterials.2018.07.011 ↗
44. Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization?10.3389/fphar.2018.00071 ↗
45. The impact of surface chemistry modification on macrophage polarisation10.1016/j.imbio.2016.06.010 ↗
46. The human tissue-biomaterial interface: a role for PPARγ-dependent glucocorticoid receptor activation in regulating the CD163+ M2 macrophage phenotype10.1089/ten.tea.2013.0628 ↗
47. Biodegradable chitosan microparticles induce delayed STAT-1 activation and lead to distinct cytokine responses in differentially polarized human macrophages in vitro10.1016/j.actbio.2014.10.026 ↗
48. Attenuation of the macrophage inflammatory activity by TiO₂ nanotubes via inhibition of MAPK and NF-κB pathways
49. MAPK signalling pathways as molecular targets for anti-inflammatory therapy–from molecular mechanisms to therapeutic benefits10.1016/j.bbapap.2005.08.017 ↗
50. 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages10.1016/j.bcp.2005.07.011 ↗
51. Protective and pathogenic functions of macrophage subsets10.1038/nri3073 ↗
52. The M1 and M2 paradigm of macrophage activation: time for reassessment10.12703/P6-13 ↗
53. Involvement of PPAR nuclear receptors in tissue injury and wound repair10.1172/JCI27958 ↗
54. The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function10.1002/jlb.66.5.733 ↗
55. Peroxisome proliferator–activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8 ↗
56. Dai · 2018 · 89 · 283
57. A well defect-suitable and high-strength biomimetic squid type II gelatin hydrogel promoted in situ costal cartilage regeneration via dynamic immunomodulation and direct induction manners10.1016/j.biomaterials.2020.119841 ↗
58. Stimulation of interleukin-1 alpha and interleukin-1 beta release from human monocytes by cyanogen bromide peptides of type II collagen10.1002/art.1780311207 ↗
59. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis10.1002/1529-0131(199910)42:10<2085::AID-ANR8>3.0.CO;2-Z ↗
60. The Regenerated Tissue at the Donor Site After Costal Cartilage Harvest for Auricular Reconstruction10.1097/SCS.0000000000005370 ↗
61. Natural large-scale regeneration of rib cartilage in a mouse model10.1002/jbmr.2326 ↗
62. Biphasic hierarchical extracellular matrix scaffold for osteochondral defect regeneration10.1016/j.joca.2017.12.001 ↗